Return to Course LibraryCE InformationPrint Course MaterialsRegister Now

Release Date:
October 25, 2017

Expiration Date:

November 1, 2021




Dr. Daniela Bernardi
Senior Radiologist and
Director of Mammography Screening Program
U.O. Senologic Clinica e Screening Mammographico
Departimento di Radiologia
Trento, Italia





Equipment Requirements
PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0


Contrast-enhanced Mammography in Clinical Practice

A free, certified recording of a one-hour live webinar for radiologists, radiologic technologists, and referring physicians

Format: Archived Webinar
Credit: 1.0 AMA PRA Category 1
Credit: 1.0 ARRT Category A
Tuition:  Free

Course Overview
In an era of high demand for breast screening exams, clinicians are continually looking for safe and effective breast cancer screening tools. This webinar will review the evidence-based literature supporting contrast-enhanced mammography (CEM), patient selection criteria, and techniques and protocols for performing CEM.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Evaluate the role of contrast-enhanced mammography (CEM) as an adjunct to digital mammography
  • Discuss patient selection and clinical indications for performing CEM
  • Describe the clinical protocols for performing CEM

ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to .

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Enroll and Participate
There are no fees or prerequisites to participate in this program.

  • Click on the blue link. Complete the precourse questions and SUBMIT.
  • Click on the blue link again to view the recording.

How to Receive Credit

  • Log-in to your account at
  • View the entire educational activity session. At the conclusion of the lecture, close the recording window.
  • Return to the course in your account at
  • From the COURSE HOME page, click the button for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, you will be able to print a certificate of credit from your account at


Dr. Daniela Bernardi
Senior Radiologist and
Director of Mammography Screening Program
U.O. Senologic Clinica e Screening Mammographico
Departimento di Radiologia
Trento, Italia

Dr. Bernardi received her medical degree from and completed her residency and fellowship in diagnostic radiology at the University School of Medicine in Verona, Italy.

Since 2009, Dr. Bernardi has been working at the Department of Radiology of APSS, Trento, primarily working in breast imaging. In 2007, she became Director of the Mammography Screening Program of the Trento province.

Dr. Bernardi’s research has mainly focused on the clinical introduction of digital breast tomosynthesis. In 2011 and 2013, she conducted two large clinical trials (STORM and STORM2), comparing this new technology to digital mammography for breast cancer screening. Since 2014, Dr. Bernardi has also used dual-energy contrast-enhanced digital mammography (CEDM), focusing her research on the clinical aspects of this methodology. She is currently conducting a new trial on the comparison between CEDM and MRI.

The author of 35 scientific publications, Dr. Bernardi studies new equipment and technologies, protocols, and approaches in breast imaging and interventional procedures. She has lectured at well over 100 national and international scientific meetings and training courses. With 18 years’ expertise in mammography, she is an acknowledged expert on all aspects of screening and diagnosis of breast disease.

Disclosure Information
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for anyone in a position to control content will be disclosed to participants prior to the start of each activity.

Dr. Bernardi has received travel support from Hologic, USA and Technologic, Italy.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Sharon Cancino 
Trace Hutchison, PharmD
Samantha Mattiucci, PharmD, CCMEP
Linda McLean, MS 
Victoria Phoenix, BS           
Jan Schultz, RN, MSN, CCMEP
Judi Smelker-Mitchek, RN, BSN                         

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

For questions regarding this program, please contact ICPME:

Jointly provided by


This activity is supported by an independent educational grant from Hologic, Inc.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.